Who is sponsoring NCT05610995?

NCT05610995 is sponsored by University Hospital, Grenoble.

What drugs are being tested in NCT05610995?

Interventions in NCT05610995: SENSIUM Patch.

What condition does NCT05610995 study?

NCT05610995 studies Premature Exit After Colorectal Surgery.

Is NCT05610995 still recruiting?

NCT05610995 is currently terminated. Last updated 29 December 2025.

Last reviewed 2025-12-29 · How we verify

NCT05610995: Colo-SENSIUM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility Study of Early Return-home After Colorectal Surgery Using a SENSIUM® Vital Parameter Monitoring Device

Terminated NA Last updated 29 December 2025

What this trial tests

NA trial testing SENSIUM Patch in Premature Exit After Colorectal Surgery in 6 participants. Terminated before completion.

Timeline

22 July 2023

Primary endpoint
8 October 2024

8 October 2024

Quick facts

Lead sponsor	University Hospital, Grenoble
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	6
Start date	22 July 2023
Primary completion	8 October 2024
Estimated completion	8 October 2024
Sites	7 locations across France

Drugs / interventions tested

SENSIUM Patch

Conditions studied

Premature Exit After Colorectal Surgery — all drugs for Premature Exit After Colorectal Surgery →

Sponsor

University Hospital, Grenoble

Who can join

18 and older, any sex, with Premature Exit After Colorectal Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The principal aim of this study is to evaluate the impact on length of stay of a return-to-home monitoring device versus enhanced rehabilitation after bowel resection surgery with anastomosis. The device SENSIUM is a tool to monitor vital signs (respiratory rate, heart rate and temperature) by applying a connected skin patch in order to detect complications early.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Grenoble trials

Trials by the same sponsor.

NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05610995 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
Last refreshed: 29 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05610995.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing